Data Foundry

Drug recalls 2026

Abiraterone Acetate Tablets USP 500 mg — Class II drug recall D-0074-2027

Ongoing recall by Glenmark Pharmaceuticals Inc., USA, reported 2026-11-04, distributed nationwide. Labeling: Not Elsewhere Classified

Recall numberD-0074-2027
Product typeDrug
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmGlenmark Pharmaceuticals Inc., USA, Elmwood Park, NJ, United States
Recall initiated2026-10-09
Classified2026-10-23
Reported by FDA2026-11-04
DistributedNationwide (US)
Quantity1,296 bottles
Reason classeslabeling
NDC68462-0135, 68462-0135-08, 68462-0882, 68462-0882-60
Lot numbers13250135
Expiration dates2027-11

Product

Abiraterone Acetate Tablets USP 500 mg, 60-count bottles, Rx only, Distributed by: Glenmark Pharmaceuticals USA, Elmwood Park, NJ 07407, NDC 68462-882-60

Reason for recall

Labeling: Not Elsewhere Classified

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0074-2027. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-11-10. Not affiliated with or endorsed by FDA. Not medical or legal advice.